ATTENTION: Please enable Javascript in your browser for full site functionality.
Skip to navigation Skip to main content Skip to footer

Class 4 Drug Caution In Use - Depo-Medrone with Lidocaine 40 mg/mL (1 mL and 2 mL vials – single vial preparations)

Recalls and Alerts

Class 4 Caution in Use

Class 4 Drug Caution In Use - Depo-Medrone with Lidocaine 40 mg/mL (1 mL and 2 mL vials – single vial preparations)

Pfizer Limited have informed the MHRA that an outdated version of the Patient Information Leaflet (PIL) has been included in the packaging of the above mentioned batches of Depo-Medrone with Lidocaine (Methylprednisolone acetate and Lidocaine hydrochloride) 40 mg/mL 1 mL and 2 mL vials (single vial presentations) to the UK market.

 

MHRA drug alert link:

https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-pfizer-limited-depo-medrone-with-lidocaine-40-mg-slash-ml-1-ml-and-2-ml-vials-single-vial-preparations-el-22-a-slash-18?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=9485c83a-e291-4936-818f-71376a60455f&utm_content=immediately

 

Pip code

Product description

Supplier

Batch Numbers

2343036

DEPO MEDRONE LIDOCAIN 40MG/ML, 1ML

PFIZER LTD

EL4771

FK6842

294892

DEPO MEDRONE LIDOCAIN 40MG/ML, 2ML

PFIZER LTD

EK3997

FK6089

FN9557

This is a caution in use only we are not accepting stock returns.

 

Further Information
If you have any questions, please contact Pfizer Medical Information Department on 01304 616161